Bacteriostatic antibiotics promote the evolution of CRISPR-Cas immunity
T. Dimitriu, E. Kurilovich, U. Lapinska, K. Severinov, S. Pagliara, M. D. Szczelkun, E. R. Westra
This study shows bacteriostatic antibiotics promote CRISPR-Cas immunity in Pseudomonas aeruginosa by slowing phage development and allowing more time for immune response.
bioRxiv · May 4, 2021 · PreprintMicrobiology